Therapeutic Advances In Hematology impact factor, indexing, ranking (2024)

---

Aim and Scope

The Therapeutic Advances In Hematology is a research journal that publishes research related to Medicine. This journal is published by the SAGE Publications Inc.. The ISSN of this journal is 20406207, 20406215. Based on the Scopus data, the SCImago Journal Rank (SJR) of therapeutic advances in hematology is 1.011.

Also, please check the following important details about therapeutic advances in hematology: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Therapeutic Advances In Hematology Ranking

The latest Impact Factor list (JCR) is released in June 2024.

The Impact Factor of Therapeutic Advances In Hematology is 3.4.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Important Metrics

Journal Title:	Therapeutic Advances in Hematology
Publisher:	SAGE Publications Inc.
ISSN:	20406207, 20406215
Type:	journal
Journal Scope:	Medicine
Country:	United States
H-Index:	32
SJR:	1.011
Quartile:	Hematology (Q2)

Indexing

The therapeutic advances in hematology is indexed in:

• UGC CARE
• Scopus
• Web of Science (SCIE)
• DOAJ
• PubMed

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Therapeutic Advances In Hematology Impact Factor 2024

The latest impact factor of therapeutic advances in hematology is 3.4 which is recently updated in June, 2024.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.

Quartile

The latest Quartile of therapeutic advances in hematology is Q2.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

Publication fee

According to journal website, the publication fee of therapeutic advances in hematology is around 2300 USD.

The therapeutic advances in hematology has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.

Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the therapeutic advances in hematology publishes research articles in 7 weeks on an average.

Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Therapeutic Advances In Hematology?

If your research is related to Medicine, then visit the official website of therapeutic advances in hematology and send your manuscript.

Tips for publishing in Therapeutic Advances In Hematology:

• Selection of research problem.
• Presenting a solution.
• Designing the paper.
• Make your manuscript publication worthy.
• Write an effective results section.
• Mind your references.

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

Sources: https://journals.sagepub.com/home/tah

---